http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1698681-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51549c66563188b40ac54da289c60d87
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B16-00
filingDate 1988-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1991-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0adf65982894b572f2a2886f01c28dce
publicationDate 1991-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SU-1698681-A1
titleOfInvention Method for determining cellular proliferation action in experimental animals after administering cancerogenic agents
abstract The invention relates to experimental oncology and can be used for the early determination of cell proliferation activity in experimental animals after the introduction of carcinogenic substances. The aim of the invention is to simplify and improve the accuracy of the method. The method is carried out by removing the adrenal glands and measuring their mass ratio. The presence of cell proliferative activity is determined by the magnitude of the corresponding ratio of the mass of the left to the mass of the right adrenal gland less than 1.0.
priorityDate 1988-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414635703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450455866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24007

Total number of triples: 17.